Danaher(DHR)
Focus: Danaher is a $23.9B diversified conglomerate headquartered in Washington, DC with 50,000+ employees, operating primarily in diagnostics and life sciences instrumentation with a significant public market presence (DHR ticker).
Profile data last refreshed 8h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
50000+
Open Jobs
1292+1214 this month
Hot — 2078 jobs added in 30d
Net +1214 (2078 new, 864 removed). Aggressive expansion phase.
Should You Work at Danaher?
AI assessmentDanaher suits professionals seeking stable, large-scale operations and diagnostic/instrumentation expertise, but not those prioritizing drug R&D velocity or a traditional pharma science track.
Why Work Here
- Scale and stability: $23.9B revenue with 50,000+ employees provides job security and internal mobility across a diversified portfolio
- Active hiring across 835 open roles with engineering (246), commercial (216), and R&D (103) leading expansion signals growth momentum
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$23.9B
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT06551116QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
N/AHelp build intelligence for Danaher
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.